CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy
Immunotherapy has become a prominent strategy for the treatment of cancer. A method thatimproves the immune system's ability to attack a tumor (Enhances antigen binding). Targetedkilling of malignant cells by adoptive transfer of chimeric antigen receptor (CAR) T cells is apromising immunothera...
Saved in:
Main Authors: | Behrouz Shademan (Author), Vahidreza Karamad (Author), Alireza Nourazarian (Author), Cigir Biray Avcı (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNAs as Targets for Cancer Diagnosis: Interests and Limitations
by: Behrouz Shademan, et al.
Published: (2023) -
Enhanced Anti-cancer Potency Using a Combination of Oleanolic Acid and Maslinic Acid to Control Treatment Resistance in Breast Cancer
by: Cigir Biray Avcı, et al.
Published: (2023) -
Identification of cancer-specific cell surface targets for CAR-T cell therapy
by: Naoki Hosen
Published: (2024) -
Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications
by: Cigir Biray Avci, et al.
Published: (2024) -
Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
by: Javad Masoumi, et al.
Published: (2021)